application) This application seeks five years of support to investigate the vascular effects of homocyst(e)ine in humans. A relationship between plasma homocysteine and atherosclerotic disease is well-recognized, but it is not yet clear whether homocyst(e)ine is a true risk factor for atherosclerosis or a marker for thromboembolic and atherosclerotic diseases. Because of in vitro evidence suggesting that homocyst(e)ine can damage vascular endothelial cells, the principal investigator and his coinvestigators have begun to examine the effects of experimental induction of hyperhomocyst(e)inemia on endothelial function in vivo in humans. This project tests the hypothesis that moderate hyperhomocyst(e)inemia causes endothelial dysfunction in humans and that this effect on the endothelium is mediated by increases in oxidant stress.
Three specific aims will be tested.
Aim I will examine the effects of chronic hyperhomocyst(e)inemia on endothelial function in both genetic and environmentally modulated models of hyperhomocyst(e)inemia, and will further study the effect of correction of plasma homocyst(e)ine levels on endothelial functional assays.
Specific Aim II will investigate whether rapid induction of abnormal plasma homocyst(e)ine levels in normal subjects by methionine loading and folate restriction leads to detectable endothelial dysfunction.
Specific Aim III will assess whether rapidly induced hyperhomocyst(e)inemia alters a variety of biochemical indices of oxidant stress and whether antioxidant therapies can reverse some or all of the endothelial function abnormalities detected in this model. Methodologies to be used include ultrasound-Doppler flow-dependent vasodilation, intra-arterial administration of pharmacologic agents with plethysmography to evaluate resistance vessel endothelial function, and non-invasive assessment of vascular structure, as well as measurement of a variety of factors important to vascular tone, platelet aggregation and coagulation. These human studies will examine further whether coexisting risk factors for atherosclerosis alter endothelial susceptibility to hyperhomocyst(e)inemia, and potential differences in the effects of homocyst(e)ine on endothelial function due to gender or race also will be explored. These studies will take advantage of a distinctive collaboration by investigators at the University of Iowa with expertise in human vascular physiology, hemostasis and thrombosis in homocyst(e)ine, and human molecular genetics. In summary, the project will provide a unique opportunity to test in vivo in humans the concept that homocyst(e)ine contributes directly to atherosclerosis by deleterious effects on endothelial function and to explore several potential mechanisms for these effects.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058972-03
Application #
6183355
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1998-05-01
Project End
2002-04-30
Budget Start
2000-05-01
Budget End
2001-04-30
Support Year
3
Fiscal Year
2000
Total Cost
$283,320
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Dopp, John M; Agapitov, Alexei V; Sinkey, Christine A et al. (2013) Sildenafil increases sympathetically mediated vascular tone in humans. Am J Hypertens 26:762-9
Fiedorowicz, Jess G; Haynes, William G (2010) Cholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa? Curr Psychiatr 9:17-A
Guthikonda, Sasidhar; Sinkey, Christine A; Haynes, William G (2007) What is the most appropriate methodology for detection of conduit artery endothelial dysfunction? Arterioscler Thromb Vasc Biol 27:1172-6
Dokras, Anuja; Jagasia, Dinesh H; Maifeld, Michelle et al. (2006) Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome. Fertil Steril 86:1702-9
Al-Shaer, Moutasim H; Choueiri, Nabil E; Correia, Marcelo L G et al. (2006) Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans. Int J Cardiol 109:201-6
Correia, Marcelo L G; Haynes, William G (2006) A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI? Arterioscler Thromb Vasc Biol 26:2183-5
Al-Shaer, Moutasim H; Raghuveer, Geetha; Browning, Roger et al. (2005) Effect of hyperhomocysteinemia induced by methionine administration on flow-mediated dilatation of the brachial artery in healthy subjects. Am J Cardiol 95:428-30
Lentz, Steven R; Haynes, William G (2004) Homocysteine: is it a clinically important cardiovascular risk factor? Cleve Clin J Med 71:729-34
Guthikonda, Sashi; Sinkey, Christine; Barenz, Therese et al. (2003) Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 107:416-21
Haynes, William G (2003) Triglyceride-rich lipoproteins and vascular function. Arterioscler Thromb Vasc Biol 23:153-5

Showing the most recent 10 out of 17 publications